Patients with hepatocellular carcinoma (HCC) release tumor cells to the bloodstream, which can be detected using cell surface markers. Despite numerous reports suggest a direct correlation between the number of circulating tumor cells (CTCs) and poor clinical outcomes, few studies have provided a thorough molecular characterization of CTCs. Due to the limited access to tissue samples in patients at advanced stages of HCC, it is crucial to develop new technologies to identify HCC cancer drivers in routine clinical conditions. Here, we describe a method that sequentially combines image flow cytometry and high density single-cell mRNA sequencing to identify CTCs in HCC patients. Genome wide expression profiling of CTCs using this approach demonstrates CTC heterogeneity and helps detect known oncogenic drivers in HCC such as IGF2. This integrated approach provides a novel tool for biomarker development in HCC using liquid biopsy.
High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma
D. D’Avola,C. Villacorta-Martin,S. Martins-Filho,Amanda J. Craig,I. Labgaa,J. von Felden,A. Kimaada,A. Bonaccorso,P. Tabrizian,B. Hartmann,R. Sebra,M. Schwartz,A. Villanueva
Published 2018 in Scientific Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Scientific Reports
- Publication date
2018-08-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-28 of 28 references · Page 1 of 1
CITED BY
Showing 1-77 of 77 citing papers · Page 1 of 1